| Veliparib with first-line chemotherapy and as maintenance therapy in ovarian cancer RL Coleman, GF Fleming, MF Brady, EM Swisher, KD Steffensen, ... New England Journal of Medicine 381 (25), 2403-2415, 2019 | 764 | 2019 |
| Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance AB Alvero, R Chen, HH Fu, M Montagna, PE Schwartz, T Rutherford, ... Cell cycle 8 (1), 158-166, 2009 | 603 | 2009 |
| Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients J de Haan, M Verheecke, K Van Calsteren, B Van Calster, RG Shmakov, ... The Lancet Oncology 19 (3), 337-346, 2018 | 334 | 2018 |
| Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting F Amant, MJ Halaska, M Fumagalli, KD Steffensen, C Lok, ... International Journal of Gynecologic Cancer 24 (3), 2014 | 289 | 2014 |
| Cancers take their Toll—the function and regulation of Toll-like receptors in cancer cells R Chen, AB Alvero, DA Silasi, KD Steffensen, G Mor Oncogene 27 (2), 225-233, 2008 | 274 | 2008 |
| The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer KD Steffensen, M Waldstrøm, I Brandslund, A Jakobsen Gynecologic oncology 117 (1), 109-116, 2010 | 140 | 2010 |
| Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer KD Steffensen, AB Alvero, Y Yang, M Waldstrøm, P Hui, JC Holmberg, ... Journal of oncology 2011, 2011 | 125 | 2011 |
| The relationship of platinum resistance and ERCC1 protein expression in epithelial ovarian cancer KD Steffensen, M WaldstrØM, A Jakobsen International Journal of Gynecologic Cancer 19 (5), 2009 | 110 | 2009 |
| Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer KD Steffensen, U Jeppesen, I Brandslund, A Jakobsen International Journal of Gynecologic Cancer 18 (4), 2008 | 100 | 2008 |
| What works in implementing patient decision aids in routine clinical settings? A rapid realist review and update from the international patient decision aid standards collaboration N Joseph-Williams, P Abhyankar, L Boland, P Bravo, AT Brenner, ... Medical Decision Making 41 (7), 907-937, 2021 | 98 | 2021 |
| Cancer in pregnancy: a survey of current clinical practice SN Han, VI Kesic, K Van Calsteren, S Petkovic, F Amant, ... European Journal of Obstetrics & Gynecology and Reproductive Biology 167 (1 …, 2013 | 94 | 2013 |
| Perspectives, fears and expectations of patients with gynaecological cancers during the COVID‐19 pandemic: A Pan‐European study of the European Network of Gynaecological Cancer … M Gultekin, S Ak, A Ayhan, A Strojna, A Pletnev, A Fagotti, AM Perrone, ... Cancer Medicine 10 (1), 208-219, 2021 | 92 | 2021 |
| Prognostic impact of prechemotherapy serum levels of HER2, CA125, and HE4 in ovarian cancer patients KD Steffensen, M Waldstrøm, I Brandslund, A Jakobsen International Journal of Gynecologic Cancer 21 (6), 2011 | 89 | 2011 |
| The prognostic importance of cyclooxygenase 2 and HER2 expression in epithelial ovarian cancer KD Steffensen, M Waldstrøm, U Jeppesen, E Jakobsen, I Brandslund, ... International Journal of Gynecologic Cancer 17 (4), 2007 | 83 | 2007 |
| European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer I Vergote, A González-Martín, I Ray-Coquard, P Harter, N Colombo, ... Annals of Oncology 33 (3), 276-287, 2022 | 82 | 2022 |
| Lessons in integrating shared decision-making into cancer care KD Steffensen, M Vinter, D Crüger, K Dankl, A Coulter, B Stuart, LL Berry Journal of oncology practice 14 (4), 229-235, 2018 | 81 | 2018 |
| Systematic development of patient decision aids: an update from the IPDAS collaboration HO Witteman, KG Maki, G Vaisson, J Finderup, KB Lewis, ... Medical Decision Making 41 (7), 736-754, 2021 | 72 | 2021 |
| Primary brain tumours, meningiomas and brain metastases in pregnancy: report on 27 cases and review of literature M Verheecke, MJ Halaska, CA Lok, PB Ottevanger, R Fruscio, ... European Journal of Cancer 50 (8), 1462-1471, 2014 | 71 | 2014 |
| The predictive value of serum VEGF in multiresistant ovarian cancer patients treated with bevacizumab MP Smerdel, KD Steffensen, M Waldstrøm, I Brandslund, A Jakobsen Gynecologic oncology 118 (2), 167-171, 2010 | 69 | 2010 |
| Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors K Dahl Steffensen, M Waldstrøm, R Fredslund Andersen, DA Olsen, ... International journal of oncology 33 (1), 195-204, 2008 | 69 | 2008 |
